Anondita Medicare Ltd (ANONDITA) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Anondita Medicare Ltd on NSE and BSE, with an AI summary of each filing.
ANONDITA MEDICARE LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 14 Nov 2026, 5:30 am
Anondita Medicare to Consider Half-Yearly Results on 14th Nov'26 Anondita Medicare Limited has notified the stock exchange that a meeting of its Board of Directors is scheduled for 14th Nov'26. The primary agenda of the meeting is to consider, review, and approve the company's unaudited financial results for the half-year ended Sep'26, alongside other routine corporate matters.
Anondita Medicare Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results (Standalone and Consolidated) of the Company for the half year ended Sep 30, 2026
Intimation · 14 Nov 2026, 5:30 am
Anondita Medicare Schedules Board Meeting on 14th Nov'26 for Half-Yearly Results Anondita Medicare Limited's Board of Directors will meet on 14th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the half year ended 30th Sep'26. In accordance with insider trading regulations, the trading window for designated persons remains closed until 48 hours post the declaration of the financial results.
Anondita Medicare Limited has informed the Exchange regarding a press release dated November 03, 2026, titled "Anondita Medicare expands business across Nepal, Bhutan and Bangladesh through new distribution partnerships".
Press Release · 03 Nov 2026, 6:16 pm
Anondita Medicare Expands Distribution Footprint Across Nepal, Bhutan, and Bangladesh Anondita Medicare Limited has entered new distribution agreements across Nepal, Bhutan, and Bangladesh to expand its international reach for COBRA condoms, personal lubricants, and surgical gloves. In Nepal, the company appointed Lotus Pharmaceuticals, SSR Traders (which has commenced sales), and Hitayu Holdings. In Bhutan, it partnered with Prema Olo Pharmaceuticals to target institutional government supply channels. In Bangladesh, agreements were finalized with National Marketing Company and R K Corporation to target northern and eastern markets across premium and economy segments.
Submission of Certificate in relation to Non- Applicability of Compliance Report on the Corporate Governance under Regulation 27 (2) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, for the Quarter ended September 30, 2026
Others (Uncategorized) · 09 Oct 2026, 11:16 pm
Anondita Medicare Confirms Exemption from Q2 SEBI Corporate Governance Reporting Anondita Medicare Limited announced on 9th Oct'26 that it is exempt from submitting the quarterly corporate governance compliance report under Regulation 27(2) of SEBI LODR Regulations for the quarter ended 30th Sep'26. Pursuant to Regulation 15(2)(b), the exemption applies due to the company's listing status on the NSE Emerge SME platform.
Anondita Medicare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 29, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 01 Oct 2026, 10:51 pm
Anondita Medicare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 29, 2026
Annual General Meeting · 30 Sept 2026, 12:48 am
Anondita Medicare Limited has informed the Exchange regarding allotment of 958166 fully paid up equity shares pursuant to Rights Issue at its meeting held on September 24, 2026
Rights Issue · 25 Sept 2026, 4:04 am
Anondita Medicare Approves Allotment of 9.58 Lakh Equity Shares via Rights Issue Anondita Medicare Limited's Board approved the allotment of 9,58,166 fully paid-up equity shares of face value ₹10 each at an issue price of ₹950 per share on 24th Sep'26, aggregating to ₹9,102.58 Lakhs under its Rights Issue (which ran from 9th Sep'26 to 22nd Sep'26). Following the allotment based on the revised issue size, the company's total paid-up equity share capital expanded from ₹18,08,66,180 (1,80,86,618 shares) to ₹19,04,47,840 (1,90,44,784 shares).
Anondita Medicare Limited has informed the Exchange regarding Outcome of Board Meeting held on September 24, 2026.
Outcome · 25 Sept 2026, 4:00 am
Anondita Medicare Approves Rights Issue Allotment of ₹91.03 Crore Anondita Medicare Limited’s Board approved the allotment of 9,58,166 equity shares of face value ₹10 each at an issue price of ₹950 per share on 24th Sep'26, aggregating up to ₹9,102.58 Lakhs via a Rights Issue. The issue was open from 9th Sep'26 to 22nd Sep'26. Following this allotment, the company's paid-up equity share capital increased from ₹18,08,66,180 (1,80,86,618 shares) to ₹19,04,47,840 (1,90,44,784 shares).
Anondita Medicare Limited has informed the Exchange regarding 'Withdrawal of Nullification Letter and confirmation of allotment of 9,58,166 Rights Equity Shares as per the Corrigendum to the Letter of Offer dated September 07, 2026 Rights Issue of Anondita Medicare Limited ( the Company )'.
Rights Issue · 25 Sept 2026, 1:59 am
Anondita Medicare Restores Revised Rights Issue Size to 9.58 Lakh Shares Anondita Medicare Limited has withdrawn its 8th Sep'26 nullification letter, fully reinstating the corrigendum dated 7th Sep'26 for its Rights Issue. Consequently, the revised issue size stands restored at 9,58,166 rights equity shares, aggregating up to ₹9,102.58 Lakhs, superseding the original 9,58,000 shares outlined in the 27th Aug'26 Letter of Offer. The company confirmed that allotment will proceed for 9,58,166 shares, and all post-allotment regulatory filings submitted to the NSE will reflect this updated issue size.
Anondita Medicare Limited has informed the Exchange that the Record Date is September 22, 2026 and the Book Closure period for the purpose of the 3rd Annual General Meeting (AGM) for the financial year 2025 26 will be from Tuesday, September 22, 2026, to Tuesday, September 29, 2026 (both days inclusive).
Others · 11 Sept 2026, 5:19 pm
Anondita Medicare Limited has informed the Exchange regarding 'INTIMATION REGARDING PARTIAL NULLIFICATION OF CORRIGENDUM TO THE LETTER OF OFFER DATED AUGUST 27, 2026'.
Others (Uncategorized) · 08 Sept 2026, 9:51 pm
Anondita Medicare Retains Original Rights Issue Size of ₹9,101 Lakhs Anondita Medicare Limited has nullified Announcement No. 1 of its 7th Sep'26 corrigendum, restoring original Letter of Offer terms dated 27th Aug'26. The rights issue remains at 9,58,000 equity shares priced at ₹950 per share, totaling ₹9,101.00 Lakhs, with ₹979.98 Lakhs allocated for general corporate purposes, reversing the proposed increase to ₹9,102.58 Lakhs. Meanwhile, provisions regarding the disposal of odd lots remain in effect, with rights entitlements traded and allotted in lots of 10 against the theoretical entitlement of 9,58,166 shares.
Anondita Medicare Limited has informed the Exchange regarding 'CORRIGENDUM TO THE LETTER OF OFFER DATED AUGUST 27, 2026'.
Others (Uncategorized) · 08 Sept 2026, 4:14 am
Anondita Medicare Revises Rights Issue Size to ₹9,102.58 Lakhs Anondita Medicare Limited issued a corrigendum on 7th Sep'26 revising its Rights Issue size from ₹9,101.00 Lakhs (9,58,000 shares) to ₹9,102.58 Lakhs (9,58,166 shares) at an issue price of ₹950 per share. The entitlement ratio stands at 97:1,831. Allocation toward General Corporate Purposes increased to ₹981.46 Lakhs, representing 10.78% of gross proceeds. Rights Entitlements will trade and be allotted in lots of 10, while equity shares trade in market lots of 200 on NSE's SME Platform, potentially creating odd-lot holdings post-allotment.
Anondita Medicare Limited has informed the Exchange regarding 'Intimation Regarding Arrangements for Disposal of Odd Lots Rights Issue of Anondita Medicare Limited '.
Rights Issue · 07 Sept 2026, 11:05 pm
Anondita Medicare Outlines Odd-Lot Trading Arrangements for Rights Issue Anondita Medicare has issued 9,58,000 Rights Equity Shares, structured as whole multiples of NSE SME's 200-share market lot. While Rights Entitlements (REs) trade in lots of 10, final post-allotment holdings might not equal multiples of 200 shares. Shareholders with odd-lot shares or REs below 10 cannot trade them via the exchange's online platform. Instead, investors must either consolidate holdings into standard market lots or dispose of/renounce odd-lot shares and REs via off-market transfers under SEBI ICDR Regulations.
Anondita Medicare Limited has informed the Exchange about Copy of Newspaper Publication pertaining to Dispatch of Notice of 03rd AGM and information relating to E- voting
Annual General Meeting · 07 Sept 2026, 1:09 am
Anondita Medicare Limited has informed the Exchange about Notice of 03rd Annual General Meeting of the Company
Annual General Meeting · 06 Sept 2026, 2:19 am
Anondita Medicare Limited has informed the Exchange regarding a press release dated September 02, 2026, titled "Anondita Medicare Declared L1 Bidder by Central Medical Services Society for Supply of Over 8 Crore Condoms".
Press Release · 02 Sept 2026, 5:56 pm
Anondita Medicare Declared L1 Bidder for 8 Crore Condom Government Tender On 2nd Sep'26, Anondita Medicare announced it was declared the L1 bidder by the Central Medical Services Society (Ministry of Health and Family Welfare) for a major government tender. The company will supply 8,00,62,000 condoms under India's Family Planning Programme. This significant allocation highlights Anondita's strong positioning in large-scale public healthcare procurement, offering substantial volume visibility. The company will utilize its automated manufacturing facility, which also produces its flagship COBRA brand, to execute this order, thereby reinforcing its domestic market footprint.
Anondita Medicare Limited has informed the Exchange regarding 'Declaration of the Company as L1 Bidder under Schedule 1 by Central Medical Services Society (CMSS)'.
Others (Uncategorized) · 01 Sept 2026, 12:02 am
Anondita Medicare Wins Tender to Supply 8.01 Crore Condoms Anondita Medicare has been declared the L1 bidder by the Central Medical Services Society (CMSS) under the Ministry of Health and Family Welfare, Government of India. The tender, finalized on 31st Aug'26, is for the free supply of 8,00,62,000 condoms for the Family Planning Programme. This significant order win secures a large volume supply contract for the company, indicating a potential boost to revenue and production volumes. The financial value of the contract was not disclosed in the filing.
Anondita Medicare Limited has informed the Exchange regarding 'Final Letter of Offer'.
Others (Uncategorized) · 29 Aug 2026, 12:40 am
Anondita Medicare Limited has informed the Exchange regarding Appointment of M/s Bahadur Murao & Co. as the Cost Auditor of the Company for the financial year 2026-2027
Change in Management · 27 Aug 2026, 10:49 pm
Anondita Medicare Appoints M/s Bahadur Murao & Co. as Cost Auditor Anondita Medicare's Board of Directors has appointed M/s Bahadur Murao & Co., Cost Accountants, as the company's Cost Auditor for the financial year 2026-27. The appointment was approved on 27 Aug'26, based on the recommendation of the Audit Committee. M/s Bahadur Murao & Co., established in 1978, is a professional firm specializing in audit, assurance, and cost advisory services. This appointment is a standard corporate governance and compliance action under Section 148 of the Companies Act, 2013.
Anondita Medicare Limited has informed the Exchange regarding Appointment of Mr GARG PIYUSH & ASSOCIATES as the Internal Auditor of the Company for the financial year 2026-2027
Change in Management · 27 Aug 2026, 10:43 pm
Anondita Medicare Appoints New Internal Auditor for FY26-27 Anondita Medicare’s Board of Directors has appointed M/s Garg Piyush & Associates (ICAI Reg No: 019331C) as the company's Internal Auditor, effective 27 Aug'26. The appointment, based on the Audit Committee's recommendation, is for the financial year 2026-2027. Established in 2014, the firm provides audit, tax, and advisory services. This corporate governance update confirms a key oversight function has been filled in compliance with SEBI regulations. The company has stated there is no relationship between the new auditor and the directors.
Anondita Medicare Limited has informed the Exchange regarding Appointment of M/s Mohit Singhal & Associates as Secretarial Auditor of the Company for the Financial year 2026-27
Change in Management · 27 Aug 2026, 10:37 pm
Anondita Medicare Appoints Secretarial Auditor for FY 2026-27 Anondita Medicare’s board approved the appointment of M/s Mohit Singhal & Associates as the Secretarial Auditor for the financial year 2026-27. The appointment was finalized at the board meeting on 27th Aug'26, following the Audit Committee's recommendation. M/s Mohit Singhal & Associates is a Delhi-based firm with expertise in corporate law, governance, and compliance. There are no disclosed relationships between the newly appointed auditor and the company's directors.
Anondita Medicare Limited has informed the Exchange regarding Outcome of Board Meeting held on August 27, 2026.
Outcome · 27 Aug 2026, 10:33 pm
Anondita Medicare Approves Rights Issue to Raise ₹9,101 Lakhs Anondita Medicare has approved a Rights Issue to raise ₹9,101 lakhs by issuing 9,58,000 equity shares at ₹950 per share. The entitlement ratio is set at 97 rights shares for every 1,831 shares held. The record date to determine eligibility is 02nd Sep'26. The issue will open on 09th Sep'26 and close on 22nd Sep'26. The funds are being raised to finance company objectives, with full subscription assumed. The company also appointed new secretarial, internal, and cost auditors for FY 2026-27.
Anondita Medicare Limited has informed the Exchange that Record date for the purpose of Rights is 02-Sep-2026.
Others · 27 Aug 2026, 9:58 pm
Anondita Medicare Sets Record Date for Rights Issue Anondita Medicare has fixed Wed, 02 Sep'26 as the record date for its upcoming rights issue of equity shares. The date will determine the shareholders eligible to receive rights entitlements under the issue. Other details of the rights issue, such as the price, ratio, and total size, have not yet been disclosed. The company's stock symbol is ANONDITA.
Anondita Medicare Limited has informed the Exchange that Board of Directors at its meeting held on August 27, 2026, has decided to issue equity shares on rights basis in the ratio of 958000 : 18086618, i.e 958000 Equity Shares for every 18086618 Equity Shares held. Issue Price is Rs. 950 per share.
Rights Issue · 27 Aug 2026, 9:47 pm
Anondita Medicare Approves ₹910.1M Rights Issue Anondita Medicare's board approved a rights issue on 27 Aug'26 to raise ₹910.1M. The company will issue 958,000 equity shares at ₹950 per share, which includes a ₹940 premium. The entitlement ratio is set at 97 rights shares for every 1,831 shares held. The record date for eligibility is 02 Sep'26. The issue will open on 09 Sep'26 and close on 22 Sep'26. On-market renunciation of rights entitlements ends on 11 Sep'26. The board also appointed new auditors for FY27.
Anondita Medicare Limited has informed the Exchange about Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals
Others (Uncategorized) · 26 Aug 2026, 4:48 pm
Anondita Medicare Receives NSE Approval for Rights Issue Anondita Medicare Limited has received in-principle approval from the NSE on 25th Aug'26 for a proposed rights issue of fully paid-up equity shares. The issue, with a face value of ₹10 per share, aims to raise up to ₹10,978.20 lakhs. This approval permits the company to proceed with the allotment of shares on a rights basis, subject to fulfilling statutory and regulatory conditions. The rights issue is a key fundraising activity that will impact the company's equity structure.